| Kemin Tsung, MD | |
|
9127 W Russell Rd Ste 110, Las Vegas, NV 89148-1253 | |
| (702) 878-0070 | |
| (702) 209-2064 |
| Full Name | Kemin Tsung |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Location | 9127 W Russell Rd Ste 110, Las Vegas, Nevada |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255306957 | NPI | - | NPPES |
| 002018196 | Medicaid | NV |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 8916 (Nevada) | Primary |
| Entity Name | Fielden,hanson,isaacs,miyada,robison,yeh Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699710749 PECOS PAC ID: 5799683462 Enrollment ID: O20031219000623 |
News Archive
NitroMed, Inc. announced today that BiDil® (isosorbide dinitrate/hydralazine hydrochloride) is being launched for the treatment of heart failure in black patients as an adjunct to current standard therapies.
Thousands of members of the National Association of Letter Carriers (NALC), an organization affiliated with the AFL-CIO, will head for scores of local bowling centers across the nation on Sunday, Nov. 6.
Progenics Pharmaceuticals, Inc. today announced the completion of the treatment phase of a 1,034-patient, one-year, open-label, international, phase 3 safety study of methylnaltrexone bromide subcutaneous injection in chronic, non-malignant pain patients with opioid-induced constipation (OIC).
Several Finnish universities have joined forces to develop an innovative drug delivery method that utilises silicon to transport drugs in the human body. Among other advances, the project has been able to sustain the effect of peptides controlling appetite, which may facilitate the use of nanotechnology for dieting purposes. The research is being carried out as part of the Academy of Finland's Research Programme on Nanoscience (FinNano).
BPA's counterpart replacement BPS can hinder heart function within minutes of a single exposure, according to a new University of Guelph study.
› Verified 6 days ago
| Entity Name | Metcalf Tiller & Chen Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811237431 PECOS PAC ID: 5698093086 Enrollment ID: O20150415001094 |
News Archive
NitroMed, Inc. announced today that BiDil® (isosorbide dinitrate/hydralazine hydrochloride) is being launched for the treatment of heart failure in black patients as an adjunct to current standard therapies.
Thousands of members of the National Association of Letter Carriers (NALC), an organization affiliated with the AFL-CIO, will head for scores of local bowling centers across the nation on Sunday, Nov. 6.
Progenics Pharmaceuticals, Inc. today announced the completion of the treatment phase of a 1,034-patient, one-year, open-label, international, phase 3 safety study of methylnaltrexone bromide subcutaneous injection in chronic, non-malignant pain patients with opioid-induced constipation (OIC).
Several Finnish universities have joined forces to develop an innovative drug delivery method that utilises silicon to transport drugs in the human body. Among other advances, the project has been able to sustain the effect of peptides controlling appetite, which may facilitate the use of nanotechnology for dieting purposes. The research is being carried out as part of the Academy of Finland's Research Programme on Nanoscience (FinNano).
BPA's counterpart replacement BPS can hinder heart function within minutes of a single exposure, according to a new University of Guelph study.
› Verified 6 days ago
| Entity Name | Reno Tahoe Anesthesia Weaver Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548816895 PECOS PAC ID: 3971930256 Enrollment ID: O20200226001459 |
News Archive
NitroMed, Inc. announced today that BiDil® (isosorbide dinitrate/hydralazine hydrochloride) is being launched for the treatment of heart failure in black patients as an adjunct to current standard therapies.
Thousands of members of the National Association of Letter Carriers (NALC), an organization affiliated with the AFL-CIO, will head for scores of local bowling centers across the nation on Sunday, Nov. 6.
Progenics Pharmaceuticals, Inc. today announced the completion of the treatment phase of a 1,034-patient, one-year, open-label, international, phase 3 safety study of methylnaltrexone bromide subcutaneous injection in chronic, non-malignant pain patients with opioid-induced constipation (OIC).
Several Finnish universities have joined forces to develop an innovative drug delivery method that utilises silicon to transport drugs in the human body. Among other advances, the project has been able to sustain the effect of peptides controlling appetite, which may facilitate the use of nanotechnology for dieting purposes. The research is being carried out as part of the Academy of Finland's Research Programme on Nanoscience (FinNano).
BPA's counterpart replacement BPS can hinder heart function within minutes of a single exposure, according to a new University of Guelph study.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kemin Tsung, MD 9127 W Russell Rd Ste 110, Las Vegas, NV 89148-1253 Ph: (702) 878-0070 | Kemin Tsung, MD 9127 W Russell Rd Ste 110, Las Vegas, NV 89148-1253 Ph: (702) 878-0070 |
News Archive
NitroMed, Inc. announced today that BiDil® (isosorbide dinitrate/hydralazine hydrochloride) is being launched for the treatment of heart failure in black patients as an adjunct to current standard therapies.
Thousands of members of the National Association of Letter Carriers (NALC), an organization affiliated with the AFL-CIO, will head for scores of local bowling centers across the nation on Sunday, Nov. 6.
Progenics Pharmaceuticals, Inc. today announced the completion of the treatment phase of a 1,034-patient, one-year, open-label, international, phase 3 safety study of methylnaltrexone bromide subcutaneous injection in chronic, non-malignant pain patients with opioid-induced constipation (OIC).
Several Finnish universities have joined forces to develop an innovative drug delivery method that utilises silicon to transport drugs in the human body. Among other advances, the project has been able to sustain the effect of peptides controlling appetite, which may facilitate the use of nanotechnology for dieting purposes. The research is being carried out as part of the Academy of Finland's Research Programme on Nanoscience (FinNano).
BPA's counterpart replacement BPS can hinder heart function within minutes of a single exposure, according to a new University of Guelph study.
› Verified 6 days ago
Mark Livingston, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 9127 W Russell Rd Ste 110, Las Vegas, NV 89148 Phone: 702-878-0070 Fax: 702-209-2064 | |
Dr. Charles Minh, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 205 Elder View Dr, Las Vegas, NV 89138 Phone: 702-907-6464 | |
Ryan Nimer, DO Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 7160 Rafael Rivera Way Ste 210, Las Vegas, NV 89113 Phone: 702-878-0070 Fax: 702-209-2064 | |
Liam Kelly Sullivan, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 7160 Rafael Rivera Way Ste 210, Las Vegas, NV 89113 Phone: 702-878-0070 Fax: 702-805-0307 | |
James Murphy, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 2635 Box Canyon Dr, Las Vegas, NV 89128 Phone: 702-386-4700 Fax: 702-386-4701 | |
Scott Young, DO Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 7250 Peak Dr Ste 100, Las Vegas, NV 89128 Phone: 702-386-4700 Fax: 702-386-4701 | |
Dr. Derek Michael Goffstein, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 7160 Rafael Rivera Way Ste 210, Las Vegas, NV 89113 Phone: 702-878-0070 Fax: 702-805-0307 |